Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2016 Mar 10;32(5):926–929. doi: 10.3904/kjim.2015.049

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 The Korean Association of Internal Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 1. — (A, B) Chest posteroanterior shows 5 cm-sized irregular mass (arrows) on right middle lobe (A). The mass much regressed after 3 months of capecitabine treatment (B). (C, D) Chest computed tomography (CT) shows no remarkable change of metastatic nodule (arrows) in left lower lobe superior segment. (E, F) Chest CT shows enlarged metastatic nodule (arrow) in left supraclavicular region (upper panel of E) and abdomen CT shows multiple metastatic lymphadenopathy (arrow) in portocaval, left para-aortic and aortocaval area (lower panel of E). After 3 months of capecitabine treatment, metastatic lymphadenopathy of the same lesion was much regressed (F).